Editas Medicine

Gary Sclar's work experience includes roles as VP & Counsel, Licensing and Transactions at Editas Medicine starting in 2023, VP & Deputy General Counsel, Strategic Initiatives at Apellis Pharmaceuticals from 2019 to 2023, Vice President, Dana-Farber Innovation at Dana-Farber Cancer Institute from 2010 to 2019, Legal Counsel at MedMetrics Health Partners from 2006 to 2010, and Licensing Associate at Partners HealthCare from 2003 to 2006.

Gary Sclar has a Doctor of Law (J.D.) degree from the Massachusetts School of Law. Gary also has a Bachelor of Science (B.S.) degree in Veterinary Sciences from the University of Massachusetts Amherst. Additionally, they hold a Master's degree from Webster University.

Apellis Pharmaceuticals

Dana-Farber Cancer Institute

Senior Manager, Quality Assurance Validation - 2465

Quality Systems Supervisor, Site Quality Assurance Operations -2468

Manager, Quality Compliance - 2470

Senior Director, Clinical Data Management

Senior Development Associate, Analytical Development - 2472

Manufacturing Associate (1st Shift, Devens)

QC Operations Analyst

Senior Director, Supply Chain

Gary Sclar

VP & Counsel, Licensing And Transactions at Editas Medicine

Org chart

Manager

Peers

Timeline

VP & Counsel, Licensing And Transactions